Brent Iverson

Iverson, Brent
Distinguished Teaching Professor in Chemistry & Biochemistry
Warren J. and Viola Mae Raymer Professor

E-mail: biverson@mail.utexas.edu

Website: http://www.cm.utexas.edu/Faculty-and-Research/Faculty-Directory/Individual-Faculty-Pages/brent_iverson

Main Office: WEL 5.320
Phone: 471-5053

Alternate Office: MBB 3.310
Phone:

Mailing Address:
The University of Texas at Austin
1 University Station A5300
Austin, TX 78712

Graduate Students:

  • Chari, Nandini
  • Demers, Marsha
  • Dzubeck-Bradford, Valerie
  • Leysath, Clint
  • Martinez, Chelsea
  • Pogson, Mark
  • Rani, Mridula
  • Samuel, Stevan
  • Seo, Min Jeong
  • Van Blarcom, Thomas
  • Post Doc Students:

  • Griswold, Karl

  • Research Summary:
       

    Antibody and enzyme engineering with an emphasis on creating better methods for improving protein function. Several new technologies have been developed and patented. Recent successes include (a) the production of improved antibodies capable of neutralizing toxins from pathogens such as anthrax and (b) altering the substrate specificity of an E. coli protease. These projects are carried out in collaboration with Dr. George Georgiou.

    Artificial macromolecules with defined higher order structure, including the first class of DNA threading polyintercalators and a unique molecular scaffold that folds into a novel pleated secondary structure. These projects examine large molecule structure and function from an organic chemistry perspective.


     
    Publications:
    Isolation of engineered, full-length antibodies from libraries expressed in Escherichia coli. (2007) Nature Biotechnology 25, 563-5.
    APEx 2-hybrid. A Quantitative Protein:Protein Interaction Assay for Antibody Discovery and Engineering (2007) Proc. Natl. Acad.. Sci. U.S.A Epub 104, 8247-52.
    Detection of Anthrax Toxin in the Serum of Animals Infected with Bacillus anthracis by Using Engineered Immunoassays (2006) Clinical and Vaccine Immunology 13, 671-677.
    Passive Protection Against Anthrax Using a High Affinity Anti-Toxin Antibody Fragment Lacking an Fc Region (2005) Infection and Immunity 73, 8362-8368.
    Engineering of Protease Variants Exhibiting High Catalytic Activity and Exquisite Substrate Selectivity (2005) Proc. Nat. Acad. of Sci., USA 102, 6855-6860.

     
    Search PubMed for more publications by Prof. Name
    (a new browser window will open)
    "Caution, this search may require more information to be accurate or specific. Check authors and institution carefully."

    Max Docs:  Pub. Date limit: